Mark A. Schroeder, Jaebok Choi, Karl Staser, John F. DiPersio 

Slides:



Advertisements
Similar presentations
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
Advertisements

Increased Plasma Indoleamine 2,3-Dioxygenase Activity and Interferon-γ Levels Correlate with the Severity of Acute Graft-versus-Host Disease after Allogeneic.
Acute Graft-versus-Host Disease: Novel Biological Insights
A Revision of Billingham’s Tenets: The Central Role of Lymphocyte Migration in Acute Graft-versus-Host Disease  Robert Sackstein  Biology of Blood and.
Preventive Azithromycin Treatment Reduces Noninfectious Lung Injury and Acute Graft- versus-Host Disease in a Murine Model of Allogeneic Hematopoietic.
Vaccination of Children following Allogeneic Stem Cell Transplantation
Pharmacokinetics of Ganciclovir after Oral Valganciclovir versus Intravenous Ganciclovir in Allogeneic Stem Cell Transplant Patients with Graft-versus-Host.
Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant 
Roles for Chemokines in Liver Disease
Allan D. Hess  Biology of Blood and Marrow Transplantation 
Allogeneic Stem Cell Transplantation in Myelofibrosis
Sympathectomy Protects Denervated Skin from Graft-Versus-Host Disease
Busulfan, Fludarabine, and Alemtuzumab As a Reduced Toxicity Regimen for Children with Malignant and Nonmalignant Diseases Improves Engraftment and Graft-versus-
Daniela Ion, Kristen Stevenson, Sook-Bin Woo, Vincent T
Reprint of: Acute Graft-versus-Host Disease: Novel Biological Insights
Mesenchymal Stromal Cells: Facilitators of Successful Transplantation?
B Cells in Chronic Graft-versus-Host Disease
Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience 
Leonardo V. Riella, Mohamed H. Sayegh  Kidney International Supplements 
Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation  Aazim K. Omer, Daniel J. Weisdorf, Aleksandr Lazaryan,
A Genetic Modifier of the Gut Microbiome Influences the Risk of Graft-versus-Host Disease and Bacteremia After Hematopoietic Stem Cell Transplantation 
Yu-Waye Chu, Ronald E. Gress 
Musculoskeletal, Neurologic, and Cardiopulmonary Aspects of Physical Rehabilitation in Patients with Chronic Graft-versus-Host Disease  Sean Robinson.
Peripheral Blood Grafts from Unrelated Donors Are Associated with Increased Acute and Chronic Graft-versus-Host Disease without Improved Survival  Mary.
Increased Programmed Death-1 Molecule Expression in Cytomegalovirus Disease and Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation 
T Cell–Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar.
Lisa A. Palmer, George E. Sale, John I
Recent Decrease in Acute Graft-versus-Host Disease in Children with Leukemia Receiving Unrelated Donor Bone Marrow Transplants  Stella M. Davies, Dan.
Helicobacter pylori Infection and Graft-versus-Host Disease
Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome  Iskra Pusic,
Improvement of Pulmonary Function with Imatinib Mesylate in Bronchiolitis Obliterans Following Allogeneic Hematopoietic Cell Transplantation  Navneet.
Visualizing the Immune Synapse
Sequential Intensified Conditioning and Tapering of Prophylactic Immunosuppressants for Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell.
The Expression of Th17-Associated Cytokines in Human Acute Graft-versus-Host Disease  Yuejun Liu, Yifeng Cai, Lan Dai, Guanghua Chen, Xiao Ma, Ying Wang,
A Novel Strategy in Managing Post-Liver Transplant Acute Graft-Versus-Host-Disease: The New Era (T)Rojan Horse  Zeyad Kanaan, MD, William Tse, MD, FACP 
Dichotomous Role of Interferon-γ in Allogeneic Bone Marrow Transplant
B Cells and Transplantation: An Educational Resource
Allogeneic Hematopoietic Stem Cell Transplantation in Adult Acute Lymphocytic Leukemia: Impact of Donor Source on Survival  Priya Kumar, Todd E. Defor,
Is There a Role for Autologous Stem Cell Transplantation for Patients with Acute Myelogenous Leukemia? A Retrospective Analysis  Nicolas Novitzky, Valda.
Can Only Partial T-Cell Depletion of the Graft before Hematopoietic Stem Cell Transplantation Mitigate Graft-versus-Host Disease While Preserving a Graft-versus-
Graft-versus-Host Disease Induced Graft-versus-Leukemia Effect: Greater Impact on Relapse and Disease-Free Survival after Reduced Intensity Conditioning 
Iron Overload Manifesting as Apparent Exacerbation of Hepatic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation  Rammurti.
Volume 143, Issue 1, Pages (July 2012)
Persistence of host dendritic cells after transplantation is associated with graft-versus- host disease  Geoffrey W. Chan, Gullu Gorgun, Kenneth B. Miller,
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and Mini-Methotrexate (Tac/Sir/MTX) as Acute Graft-versus-Host Disease.
CD3+/Tregs Ratio in Donor Grafts Is Linked to Acute Graft-versus-Host Disease and Immunologic Recovery after Allogeneic Peripheral Blood Stem Cell Transplantation 
The Hematopoietic Cell Transplant Pharmacist: Roles, Responsibilities, and Recommendations from the ASBMT Pharmacy Special Interest Group  Amber B. Clemmons,
Regression Models for Hazard Rates Versus Cumulative Incidence Probabilities in Hematopoietic Cell Transplantation Data  Brent R. Logan, Mei-Jie Zhang,
Diarrhea during the Conditioning Regimen Is Correlated with the Occurrence of Severe Acute Graft-versus-Host Disease through Systemic Release of Inflammatory.
Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews  Emily C. Merkel, Sandra A. Mitchell,
Unrelated Stem Cell Transplantation after a Reduced Intensity Conditioning Regimen Containing High-Dose Thymoglobulin Leads to Controllable Graft-versus-Host.
John E. Levine, Sophie Paczesny, Stefanie Sarantopoulos 
Anniek B. van der Waart, Walter J. F. M. van der Velden, Nicole M
Chimeric Antigen Receptor–Modified T Cells: Clinical Translation in Stem Cell Transplantation and Beyond  Stanley R. Riddell, Michael C. Jensen, Carl.
Allogeneic Hematopoietic Stem Cell Transplantation in FLT3-ITD–Positive Acute Myelogenous Leukemia: The Role for FLT3 Tyrosine Kinase Inhibitors Post-
Comparison of Outcomes after Peripheral Blood Haploidentical versus Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients.
Blood and Marrow Transplant Handbook
Young Female Donors Do Not Increase the Risk of Graft-versus-Host Disease or Impact Overall Outcomes in Pediatric HLA-Matched Sibling Hematopoietic Stem.
Current Graft-versus-Host Disease–Free, Relapse-Free Survival: A Dynamic Endpoint to Better Define Efficacy after Allogenic Transplant  Scott R. Solomon,
Low Serum Levels of Total Rabbit-IgG Is Associated with Acute Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation:
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
Alveolar Hemorrhage and Acute Graft-versus-Host Disease
John Koreth, Edwin P. Alyea, William J. Murphy, Lisbeth A. Welniak 
Mammen Chandy  Biology of Blood and Marrow Transplantation 
Treatment versus Transplant for Challenging Hematologic Disorders
Prospective Monitoring of Tumor Necrosis Factor α and Interferon γ to Predict the Onset of Acute and Chronic Graft-versus-Host Disease after Allogeneic.
Alwi Shatry, Jackeline Chirinos, Michael A
Mary Eapen  Biology of Blood and Marrow Transplantation 
In Memoriam: E. Donnall Thomas
Cytotoxic T Lymphocyte Antigen-4 Down-Regulates T Helper 1 Cells by Increasing Expression of Signal Transducer and Activator of Transcription 3 in Acute.
Presentation transcript:

The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia  Mark A. Schroeder, Jaebok Choi, Karl Staser, John F. DiPersio  Biology of Blood and Marrow Transplantation  Volume 24, Issue 6, Pages 1125-1134 (June 2018) DOI: 10.1016/j.bbmt.2017.12.797 Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 JAK Activity in aGVHD. (A) The conditioning regimen may cause the release of inflammatory cytokines [6], which signal through JAKs to activate APCs [29,38,39]; activated macrophages migrate toward CXCL9 secreted from lymph nodes in a JAK1/JAK2-dependent process [29]. (B) After HCT, JAKs regulate allogenic donor T-cell activation through secondary signals in APCs, such as CD80/86 [40], IDO, and IFN signaling [40], and in T cells downstream of the γ-chain cytokine receptor [9,41]. JAK activity in CD4+ and CD8+ T cells also promotes proliferation, whereas JAK signaling inhibits proliferation of Tregs [23]. (C) After T-cell activation, migration out of the secondary lymphoid tissue is regulated by chemokine receptors, which are in turn regulated by JAK signaling [7,26,42-47]. T-cell cytotoxic activity, including granzyme B (GB) production, is promoted by JAK activity [23,26]. Neutrophils, which may participate in GVHD [48], use JAK signaling pathways to regulate their development and activity [49]. DAMP, damage-associated molecular pattern; IDO, indoleamine 2,3 dioxygenase; PAMP, pathogen-associated molecular pattern; PD-1, programmed cell death protein 1; PD-L1, programmed cell death protein ligand 1. Biology of Blood and Marrow Transplantation 2018 24, 1125-1134DOI: (10.1016/j.bbmt.2017.12.797) Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions